HMOX1 and neoplasm: E. Alaluf reported that the absence of HO-1 enhanced the therapeutic effects of anti-tumor vaccines in vivo experiments by restoring CD8+ T cell proliferation and cytotoxicity (Alaluf et al., 2020), suggesting HO-1 as a potential therapeutic target.